MENU
+Compare
WINT
Stock ticker: NASDAQ
AS OF
Dec 18, 04:58 PM (EDT)
Price
$0.36
Change
-$0.02 (-5.26%)
Capitalization
3.33M

WINT Windtree Therapeutics Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceuticals

Industry Biotechnology
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for WINT with price predictions
Dec 17, 2024

WINT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on December 05, 2024

WINT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 52 cases where WINT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where WINT's RSI Oscillator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WINT advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 04, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on WINT as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WINT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for WINT entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.754) is normal, around the industry mean (14.664). P/E Ratio (0.826) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). WINT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. WINT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WINT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

WINT is expected to report earnings to fall 19.11% to -1050 cents per share on May 17

Windtree Therapeutics WINT Stock Earnings Reports
Q1'23
Est.
$-10.50
Q4'22
Missed
by $2.48
Q3'22
Beat
by $0.13
Q2'22
Missed
by $0.41
Q1'22
Beat
by $0.01
The last earnings report on March 30 showed earnings per share of -1297 cents, missing the estimate of -1050 cents. With 320.53K shares outstanding, the current market capitalization sits at 3.33M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2600 Kelly Road
Phone
+1 215 488-9300
Employees
20
Web
https://www.windtreetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IRMD53.00-0.18
-0.34%
iRadimed Corp
WWD172.62-2.10
-1.20%
Woodward
DCTH11.94-0.28
-2.29%
Delcath Systems
HEES53.20-1.83
-3.33%
H&E Equipment Services
ARTL1.02-0.04
-3.77%
Artelo Biosciences

WINT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been loosely correlated with MLEC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WINT jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
-3.77%
MLEC - WINT
49%
Loosely correlated
-5.74%
DVHGF - WINT
37%
Loosely correlated
N/A
INMB - WINT
31%
Poorly correlated
-1.97%
ESLA - WINT
29%
Poorly correlated
-3.15%
CDTX - WINT
27%
Poorly correlated
-1.93%
More